These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 9734620

  • 1. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 2. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
    Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW.
    Transplantation; 1999 Nov 15; 68(9):1325-31. PubMed ID: 10573071
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.
    Transplantation; 1998 Dec 27; 66(12):1632-40. PubMed ID: 9884251
    [Abstract] [Full Text] [Related]

  • 4. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group.
    Transplantation; 2001 Sep 27; 72(6):1024-32. PubMed ID: 11579295
    [Abstract] [Full Text] [Related]

  • 5. The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients.
    Goel M, Flechner SM, Ischikawa A, Induhara R, Mastroianni B, Savas K, Modlin C, Goldfarb D, Feng J, Cook DJ, Novick AC.
    Clin Transplant; 2002 Dec 27; 16(6):442-9. PubMed ID: 12437625
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA.
    Transplantation; 1998 Jun 15; 65(11):1455-60. PubMed ID: 9645802
    [Abstract] [Full Text] [Related]

  • 7. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 Jun 15; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 8. Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation.
    Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Dahlke LJ, Wilson SM, Steers JL, Krom RA.
    Transplantation; 1997 Sep 15; 64(5):726-31. PubMed ID: 9311710
    [Abstract] [Full Text] [Related]

  • 9. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.
    Clin Transplant; 1998 Oct 15; 12(5):379-90. PubMed ID: 9787945
    [Abstract] [Full Text] [Related]

  • 10. NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation.
    Alvarez F, Atkison PR, Grant DR, Guilbault N, Jones AB, Kim PS, Kneteman NM, Laurin L, Martin SR, Murphy GF, Paradis K, Shapiro J, Smith LJ, Superina RA.
    Transplantation; 2000 Jan 15; 69(1):87-92. PubMed ID: 10653385
    [Abstract] [Full Text] [Related]

  • 11. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM, Mueller EA, Richard F, Niese D, Halloran PF, Jeffery J, Paul LC, Keown PA.
    Transplantation; 1996 Sep 27; 62(6):759-63. PubMed ID: 8824473
    [Abstract] [Full Text] [Related]

  • 12. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.
    Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffery J, Russell D, Stiller C, Muirhead N, Cole E, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, Boucher A, Handa P, Lawen J, Belitsky P, Parfrey P.
    Transplantation; 1996 Dec 27; 62(12):1744-52. PubMed ID: 8990355
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF.
    Pediatr Transplant; 1998 Feb 27; 2(1):35-9. PubMed ID: 10084758
    [Abstract] [Full Text] [Related]

  • 14. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S, Niese D.
    Transpl Int; 1994 Feb 27; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [Abstract] [Full Text] [Related]

  • 15. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H, Wagner C, Korn A, Christians U.
    Med Klin (Munich); 1997 Oct 15; 92(10):589-96. PubMed ID: 9446006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE, Danguilan RA, Lamban AB, Mangati VB, Ona ET.
    Transplant Proc; 2012 Jan 15; 44(1):101-8. PubMed ID: 22310590
    [Abstract] [Full Text] [Related]

  • 19. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A, Steel L, Sharples L, Stewart S, Parameshwar J, McNeil K, Wallwork J.
    Ther Drug Monit; 1999 Feb 15; 21(1):17-26. PubMed ID: 10051050
    [Abstract] [Full Text] [Related]

  • 20. Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups.
    Keown PA.
    Transplant Proc; 1996 Aug 15; 28(4):2147-50. PubMed ID: 8769183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.